All relevant information on the start of the Phase II trial
On March 7, 2018, MetrioPharm announced “First Patient First Dose” for its ongoing Phase II clinical trial, a “multi-center, double-blind, placebo-controlled, clinical trial in the indication psoriasis.”
For our blog, we have collected the keywords from this press release and explain what they mean in concrete terms for MetrioPharm and our ongoing trial.
Phase II trial
A medical substance ...